EP 2528926 A4 20130619 - HEPATITIS C INHIBITOR COMPOUNDS
Title (en)
HEPATITIS C INHIBITOR COMPOUNDS
Title (de)
HEPATITIS-C-HEMMER-VERBINDUNGEN
Title (fr)
COMPOSÉS INHIBITEURS DU VIRUS DE L'HÉPATITE C
Publication
Application
Priority
- US 32790010 P 20100426
- US 29918610 P 20100128
- CA 2011050041 W 20110124
Abstract (en)
[origin: WO2011091532A1] Compounds of Formula (I): wherein R1, R2, RA, RB, Z1, Z2, Z3, Z4, Z5 and Z6 are defined herein. The compounds are useful as inhibitors of the function of NS5A protein encoded by HCV for the treatment of hepatitis C viral infection.
IPC 8 full level
C07D 519/00 (2006.01); A61K 31/439 (2006.01); A61K 31/444 (2006.01); A61K 31/506 (2006.01); A61P 31/14 (2006.01)
CPC (source: EP)
A61P 31/14 (2017.12); C07D 401/14 (2013.01); C07D 403/14 (2013.01)
Citation (search report)
- [E] WO 2011031904 A1 20110317 - ENANTA PHARM INC [US], et al
- See references of WO 2011091532A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2011091532 A1 20110804; EP 2528926 A1 20121205; EP 2528926 A4 20130619; JP 2013518062 A 20130520
DOCDB simple family (application)
CA 2011050041 W 20110124; EP 11736580 A 20110124; JP 2012550280 A 20110124